Pfizer to cut 2,000 jobs

As Pfizer and Wyeth prepare for their merger, six out of the 20 combined research facilities will get closed. You can expect to see a heavy amount of reorganizing, consolidation, etc. This will result in the loss of 2,000 jobs (scientists, lab technicians, etc.).

These are very difficult times for people working in pharma. As jobs get cut, where do people go? Most look for other jobs in pharma. There's no security wherever you go. You could be a very loyal employee and your job may still get cut. I wonder if these pharma stories are causing some physicians to think twice before they leave their "stable" clinical careers.

The Health Industry and the Stock Market

So much is changing in the healthcare industry. Have you spoken with your stock broker? If you're like me, then you probably try to do everything online. I'm a big fan of Online Trading. Why? Because it's so convenient and you can easily make changes easily by getting on a computer and logging in to your favorite Online Broker. It's easy for me since I'm always carring some type of computer around (usually an ultra-mobile PC that is connected to the Internet). The Internet has simplified so many things, including Stock Trading. It's hard to imagine what the world was like before we had the World Wide Web.

Who do you use to trade Stocks, Options, Mutual Funds, ETFs and Fixed Incomes? Pharmaceutical companies are merging, others are downsizing to reduce costs. Pfizer is merging with Wyeth. Schering-Plough is merging with Merck. Roche is aquiring Genentech. This may not be the best time to leave a job in clinical medicine to join the folks in pharma. With all these mergers and acquisitions, Stock Trading must be going crazy these days. The stock market has been in a downhill tumble and no one seems to know what's going to happen in the market. There is so much uncertainly about the current economy. What services or tools do you use for Online Trading?

Will Pfizer Buy Wyeth for $60 Billion?

Rumors are circulating... it's still way too early to say, but it sure is an interesting headline. Maybe it won't be for $60 billion. Maybe only $59 billion?